What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

Early in the Covid-19 pandemic, the governor of New Jersey made an unusual admission: He’d run out of COBOL developers. The state’s unemployment insurance systems were written in the 60-year-old ...

[Maximilian Milovidov is a freshman at Columbia University and a member of TikTok's Youth Council. He used a large language model to edit this essay for length and a human to edit for content. This ...

Shrishty is a decade-old journalist covering a variety of beats between politics to pop culture, but movies are her first love, which led her to study Film and TV Development at UCLAx. She lives and ...

Suffering from hair envy? You can now use the same hair products that Manon, Yoonchae, Sophia, Megan, Lara, and Daniela use to get their glossy locks. Manon's go-to products from Matrix are a ...

Texas’ medical marijuana program is expanding, with new laws now in effect that increase access for patients across the state, including in North Texas. While much of the debate in 2025 centered on ...

Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...

Costco's Auto Program should be as popular as its $5 rotisserie chicken — but I've learned not too many of its members actually know it exists. I discovered the program this past summer during a ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...